Plaque Psoriasis Latest Advances

Real-World Efficacy and Safety of Ixekizumab in the Treatment of Psoriasis: A Case-Series from Indian Sub-Continent.

Journal: Indian journal of dermatology

Published: September 08, 2026

Practical Saudi Guidelines on management of moderate-to-severe psoriasis: 2026 update.

Journal: The Journal of dermatological treatment

Published: September 07, 2026

Eczematous eruption during bimekizumab treatment for plaque psoriasis: a biopsy-confirmed case with elevated serum TARC and peripheral eosinophilia.

Journal: European journal of dermatology : EJD

Published: August 31, 2026

Correction to: Efficacy and safety of ustekinumab biosimilars for treating moderate‑to‑severe plaque psoriasis: a systematic review and network meta‑analysis.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: August 26, 2026

Topical treatment of psoriasis with calcipotriol/betamethasone dipropionate cream in real-life clinical practice: expert opinion.

Journal: Italian journal of dermatology and venereology

Published: August 24, 2026

Probable paradoxical pyoderma gangrenosum associated with secukinumab in a patient with severe plaque psoriasis.

Journal: JAAD case reports

Published: August 23, 2026

IL-17A Restrains Antiviral Immunity to Promote Chikungunya Virus Infection and Pathogenesis in the Heart.

Journal: bioRxiv : the preprint server for biology

Published: August 20, 2026

Effectiveness of brodalumab in biologic-experienced adults with moderate to severe plaque psoriasis: a focused narrative review.

Journal: The Journal of dermatological treatment

Published: August 12, 2026

Refractory verrucous psoriasis achieving clearance with guselkumab and subsequent response to excimer therapy.

Journal: JAAD case reports

Published: August 09, 2026

When Skin Disease Affects Intimacy: The Ethical Duty for Dermatologists to Screen for Sexual Dysfunction.

Journal: Clinics in dermatology

Published: August 08, 2026

Clinical characteristics and outcomes of paradoxical palmoplantar pustulosis during secukinumab therapy in biologic-naïve patients with plaque psoriasis: a retrospective case series.

Journal: The Journal of dermatological treatment

Published: August 07, 2026

Evaluating Zasocitinib as an oral therapy for moderate to severe plaque Psoriasis.

Journal: Expert opinion on pharmacotherapy

Published: August 05, 2026

Plaque Psoriasis Latest Advances

Find the Latest Research About Plaque Psoriasis

Real-World Efficacy and Safety of Ixekizumab in the Treatment of Psoriasis: A Case-Series from Indian Sub-Continent.

Real-World Efficacy and Safety of Ixekizumab in the Treatment of Psoriasis: A Case-Series from Indian Sub-Continent.

Practical Saudi Guidelines on management of moderate-to-severe psoriasis: 2026 update.

Practical Saudi Guidelines on management of moderate-to-severe psoriasis: 2026 update.

Eczematous eruption during bimekizumab treatment for plaque psoriasis: a biopsy-confirmed case with elevated serum TARC and peripheral eosinophilia.

Eczematous eruption during bimekizumab treatment for plaque psoriasis: a biopsy-confirmed case with elevated serum TARC and peripheral eosinophilia.

Correction to: Efficacy and safety of ustekinumab biosimilars for treating moderate‑to‑severe plaque psoriasis: a systematic review and network meta‑analysis.

Correction to: Efficacy and safety of ustekinumab biosimilars for treating moderate‑to‑severe plaque psoriasis: a systematic review and network meta‑analysis.

Topical treatment of psoriasis with calcipotriol/betamethasone dipropionate cream in real-life clinical practice: expert opinion.

Topical treatment of psoriasis with calcipotriol/betamethasone dipropionate cream in real-life clinical practice: expert opinion.

Probable paradoxical pyoderma gangrenosum associated with secukinumab in a patient with severe plaque psoriasis.

Probable paradoxical pyoderma gangrenosum associated with secukinumab in a patient with severe plaque psoriasis.

IL-17A Restrains Antiviral Immunity to Promote Chikungunya Virus Infection and Pathogenesis in the Heart.

IL-17A Restrains Antiviral Immunity to Promote Chikungunya Virus Infection and Pathogenesis in the Heart.

Effectiveness of brodalumab in biologic-experienced adults with moderate to severe plaque psoriasis: a focused narrative review.

Effectiveness of brodalumab in biologic-experienced adults with moderate to severe plaque psoriasis: a focused narrative review.

Refractory verrucous psoriasis achieving clearance with guselkumab and subsequent response to excimer therapy.

Refractory verrucous psoriasis achieving clearance with guselkumab and subsequent response to excimer therapy.

When Skin Disease Affects Intimacy: The Ethical Duty for Dermatologists to Screen for Sexual Dysfunction.

When Skin Disease Affects Intimacy: The Ethical Duty for Dermatologists to Screen for Sexual Dysfunction.

Clinical characteristics and outcomes of paradoxical palmoplantar pustulosis during secukinumab therapy in biologic-naïve patients with plaque psoriasis: a retrospective case series.

Clinical characteristics and outcomes of paradoxical palmoplantar pustulosis during secukinumab therapy in biologic-naïve patients with plaque psoriasis: a retrospective case series.

Evaluating Zasocitinib as an oral therapy for moderate to severe plaque Psoriasis.

Evaluating Zasocitinib as an oral therapy for moderate to severe plaque Psoriasis.